Brittany L Bychkovsky

11PUBLICATIONS
90CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birthImmunogenetics (incl. genetic immunology)Gene expression (incl. microarray and other genome-wide approaches)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 03, 2025
A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2-Mutated Metastatic Breast Cancer.

Filipa Lynce, Noah Graham, Bose S Kochupurakkal

|Oct 08, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil.

Romualdo Barroso-Sousa, Danielle Laperche-Santos, Heloisa Resende

|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

|Apr 22, 2025
Low Allele Frequency Variants Identified on Germline Multi-Gene Panel Testing for Cancer Predisposition Can Suggest the Presence of Constitutional Mosaicism.

Adela Rodriguez-Hernandez, Linda M Polfus, Brittany L Bychkovsky

|Nov 27, 2024
Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye.

Ozkan Ozdemir, Brittany L Bychkovsky, Busra Unal

|Apr 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer.

Stefania Morganti, Qingchun Jin, Julie Vincuilla

Pageof 2

Frequent Collaborators

6 joint publications

Sara M Tolaney

4 joint publications

Filipa Lynce

3 joint publications

Giuseppe Curigliano

3 joint publications

Lynette Sholl